Corinne Hoesli, ing., PhD, Prof., Canada Research Chair in Cellular Therapy Bioprocess Engineering

Prof. Hoesli is the head of the Stem Cell Bioprocessing Laboratory at McGill University. She is co-director of the Quebec Cell, Tissue and Gene Therapy Network – ThéCell, and a member of the McGill Regenerative Medicine network executive committee. She is a biochemical engineer with expertise in bioprocess development, stem cell culture optimization and encapsulation device engineering. Her research aims to develop bioprocesses to produce and transplant therapeutic cells to treat diabetes and cardiovascular disease. Her laboratory studies how cell culture materials impact stem cell and progenitor cell differentiation into useful therapeutic products. To biomanufacture cell-based products at scale, she works with companies and organizations such as the Canadian National Research Council to tailor bioreactor design and operation parameters. To improve cell survival after transplantation, her laboratory is developing vascular biomaterials and 3D printing methods to create vascularized tissues.  Over the past 5 years, Prof. Hoesli and her team have published over 20 articles in leading bioprocess engineering journals, as well as several patents related to cell culture materials and transplantation devices. Her emerging leadership in bioengineering was recognized through the 2014 Martin Sinacore Outstanding Young Investigator Award from Engineering Conferences International & Biogen Idec, as well as the 2019 “Étoiles effervescence” award from Montreal InVivo.